Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Psoriatic onychodystrophy

From Wikipedia, the free encyclopedia
(Redirected fromPsoriatic nails)
Medical condition
Psoriatic onychodystrophy
Other namesPsoriatic nails,Psoriatic onychopathy
A picture of a pair of feet in sandals. Some of the nails appear diseased.
Psoriasis of the toenails
SpecialtyDermatology
CausesPsoriasis
Differential diagnosisOnychomycosis
TreatmentMedications, radiation
Frequency10% to 78% of those with psoriasis

Psoriatic onychodystrophy (also termedpsoriatic nails orpsoriatic onychopathy) is anail disease which is common in those withpsoriasis, with reported incidences varying from 10% to 78%. Elderly patients and those withpsoriatic arthritis are more likely to have psoriatic nails.[1]: 781–2 

Symptoms

[edit]

Psoriatic nails are characterized by a translucent discolouration in the nail bed that resembles a drop of oil beneath the nail plate.[2] Early signs that may accompany the "oil drop" include thickening of the lateral edges of the nail bed with or without resultant flattening or concavity of the nail; separation of the nail from the underlying nail bed, often in thin streaks from the tip-edge to the cuticle; sharp peaked "roof-ridge" raised lines from cuticle to tip; or separation of superficial layers of the nail followed by loss of patches of these superficial layers, leaving thin red nails beneath; or nail pitting–punctate changes along the nail plate surface.

Causes

[edit]

The causes of nail psoriasis are unknown. It has been suggested thatfungi may play a role.[3]

Diagnosis

[edit]

The Nail Psoriasis Severity Index (NAPSI) is a numeric, reproducible, objective, simple tool for evaluation of nail psoriasis.[4] It evaluates several signs separately, each on a 1–3 scale: pitting,Beau's lines,subungual hyperkeratosis andonycholysis. A 2005 study proposed a modified NAPSI scale for persons with psoriasis and named the title of their publication "Modification of the Nail Psoriasis Severity Index".[5] Then, in 2007, a study found that there was a high level of inter-rater variability of the 2003 NAPSI scale and proposed another index which was, like the 2005 article, a modification of the 2003 article, and was named modified NAPSI.[6]

A 2008 study found that Cannavo's qualitative system[7] correlated with NAPSI (p<0.001) and is less time-consuming.[8]

Onycholysis: Separation of the nail plate from the nail bed

There is a risk of misdiagnosis withonychomycosis.

Treatment

[edit]

There exist numerous treatments for nail psoriasis but there is little information concerning their effectiveness and safety.[9]Treatments include topical, intralesional, radiation, systemic, and combination therapies.

Relative effectiveness of treatments

[edit]

Available studies lack sufficient power to extrapolate a standardized therapeutic regimen.[9]

As of April 2009,[needs update] an assessment of the evidence for the efficacy and safety of the treatments for nail psoriasis is in progress.[20]

  • Infliximab appears to be the most effective treatment for nail psoriasis to date.[21]
  • Results from low-dose acitretin therapy show NAPSI score reductions comparable with those studies evaluating biologic drugs for nail psoriasis and suggest that low-dose systemic acitretin should be considered in the treatment of nail psoriasis.[21]

A 2013 meta-analysis showed improvement of nail psoriasis with infliximab, golimumab, superficial radiotherapy,electron beam, andgrenz rays compared toplacebo.[22] Although systemic therapies have been shown to be beneficial, they may have serious adverse effects.[22]Topical treatments have not been well studied but may be beneficial.[22]

Research

[edit]

Active clinical trials investigating nail psoriasis:[23]

Phase IV

[edit]

Phase II

[edit]

See also

[edit]

References

[edit]
  1. ^James, William; Berger, Timothy; Elston, Dirk (2005).Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders.ISBN 0-7216-2921-0.
  2. ^Kouskoukis, C.; Scher, R.; Ackerman, A. (1983). "The "oil drop" sign of psoriatic nails. A clinical finding specific for psoriasis".The American Journal of Dermatopathology.5 (3):259–262.doi:10.1097/00000372-198306000-00012.PMID 6625117.
  3. ^Szepietowski, C.; Salomon, J. (Nov 2007). "Do fungi play a role in psoriatic nails?".Mycoses.50 (6):437–442.doi:10.1111/j.1439-0507.2007.01405.x.ISSN 0933-7407.PMID 17944702.S2CID 37127086.
  4. ^Rich, P.; Scher, R. (2003). "Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis".Journal of the American Academy of Dermatology.49 (2):206–212.doi:10.1067/S0190-9622(03)00910-1.PMID 12894066.
  5. ^Parrish, CA; Sobera, JO; Elewski, BE (October 2005). "Modification of the Nail Psoriasis Severity Index".Journal of the American Academy of Dermatology.53 (4):745–6, author reply 746–7.doi:10.1016/j.jaad.2004.11.044.PMID 16198816.
  6. ^Cassell, S.; Bieber, J.; Rich, P.; Tutuncu, Z.; Lee, S.; Kalunian, K.; Wu, C.; Kavanaugh, A. (2007). "The modified Nail Psoriasis Severity Index: Validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis".The Journal of Rheumatology.34 (1):123–129.PMID 17216680.
  7. ^Cannavò, S. P.; Guarneri, F.; Vaccaro, M.; Borgia, F.; Guarneri, B. (2003). "Treatment of Psoriatic Nails with Topical Cyclosporin: A Prospective, Randomized Placebo-Controlled Study".Dermatology.206 (2):153–156.doi:10.1159/000068469.PMID 12592084.S2CID 20866096.
  8. ^Kaçar, N.; Ergin, Ş.; Erdo?an, B. (2007). "The comparison of Nail Psoriasis Severity Index with a less time-consuming qualitative system".Journal of the European Academy of Dermatology and Venereology.22 (2):219–22.doi:10.1111/j.1468-3083.2007.02389.x.PMID 18211416.S2CID 41847018.
  9. ^abJiaravuthisan, M. M.; Sasseville, D.; Vender, R. B.; Murphy, F.; Muhn, C. Y. (2007). "Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy".Journal of the American Academy of Dermatology.57 (1):1–27.doi:10.1016/j.jaad.2005.07.073.PMID 17572277.
  10. ^Balbás, G. M.; Regaña, M. S.; Millet, P. U. (2009). "Tacalcitol ointment for the treatment of nail psoriasis".Journal of Dermatological Treatment.20 (5):308–310.doi:10.1080/09546630902787585.PMID 19367480.S2CID 208249471.
  11. ^Snchez Regaa, M.; Mrquez Balbs, G.; Umbert Millet, P. (2008)."Nail psoriasis: A combined treatment with 8 clobetasol nail lacquer and tacalcitol ointment".Journal of the European Academy of Dermatology and Venereology.22 (8):963–969.doi:10.1111/j.1468-3083.2008.02679.x.PMID 18410337.
  12. ^Fiallo, P. (2009). "Yellow nails as an adverse reaction to the topical use of 5-fluorouracil for the treatment of nail psoriasis".Journal of Dermatological Treatment.20 (5):299–301.doi:10.1080/09546630902773494.PMID 19363737.S2CID 42262387.
  13. ^Tzung, T.; Chen, C.; Yang, C.; Lo, P.; Chen, Y. (2008)."Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis".Acta Dermato-Venereologica.88 (3):279–280.doi:10.2340/00015555-0401.PMID 18480933.
  14. ^Rigopoulos, D.; Gregoriou, S.; Daniel, III, C. R.; Belyayeva, H.; Larios, G.; Verra, P.; Stamou, C.; Kontochristopoulos, G.; Avgerinou, G.; Katsambas, A. (2009). "Treatment of Nail Psoriasis with a Two-Compound Formulation of Calcipotriol plus Betamethasone Dipropionate Ointment".Dermatology.218 (4):338–341.doi:10.1159/000202179.PMID 19212110.S2CID 36470967.
  15. ^Lamerson, C.; Stevens, G.; Sax, K. (2008). "Treatment of nail psoriasis with efalizumab: A preliminary study".Cutis; Cutaneous Medicine for the Practitioner.82 (3):217–220.PMID 18856162.
  16. ^Rigopoulos, D.; Gregoriou, S.; Stratigos, A.; Larios, G.; Korfitis, C.; Papaioannou, D.; Antoniou, C.; Ioannides, D. (2008). "Evaluation of the efficacy and safety of infliximab on psoriatic nails: An unblinded, nonrandomized, open-label study".British Journal of Dermatology.159 (2):453–456.doi:10.1111/j.1365-2133.2008.08686.x.PMID 18565184.S2CID 205257408.
  17. ^abClinical trial numberNCT00265096 for "A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis (GO-REVEAL)" atClinicalTrials.gov
  18. ^Lee, Julia Yu-Yun (November 2009)."Severe 20-nail psoriasis successfully treated by low dose methotrexate".Dermatology Online Journal.15 (11): 8.doi:10.5070/D32XF4V4PW.PMID 19951644.
  19. ^Saleem, K.; Azim, W. (2008). "Treatment of nail psoriasis with a modified regimen of steroid injections".Journal of the College of Physicians and Surgeons Pakistan.18 (2):78–81.PMID 18454890.
  20. ^Velema, Marieke; Hooft, Lotty; Lebwohl, Mark; Spuls, Phyllis I (2009). Spuls, Phyllis I (ed.). "Interventions for nail psoriasis".Protocols (1) CD007633.doi:10.1002/14651858.CD007633.hdl:2066/118676.PMID 23440816.
  21. ^abNoiles, K.; Vender, R. (2009). "Nail psoriasis and biologics".Journal of Cutaneous Medicine and Surgery.13 (1):1–5.doi:10.2310/7750.2008.08012.PMID 19298765.S2CID 26612674.
  22. ^abcde Vries, Anna Christa Q; Bogaards, Nathalie A; Hooft, Lotty; Velema, Marieke; Pasch, Marcel; Lebwohl, Mark; Spuls, Phyllis I (2013-01-31)."Interventions for nail psoriasis".Cochrane Database of Systematic Reviews (1) CD007633.doi:10.1002/14651858.CD007633.pub2.hdl:2066/118676.ISSN 1465-1858.PMC 11611064.PMID 23440816.
  23. ^clinicaltrials.gov
  24. ^Clinical trial numberNCT00581100 for "Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis" atClinicalTrials.gov
  25. ^Clinical trial numberNCT00666354 for "Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail Psoriasis" atClinicalTrials.gov

External links

[edit]
Classification


Psoriasis
Pustular
Other
Parapsoriasis
Otherpityriasis
Otherlichenoid
Lichen planus
Other
Disorders ofskin appendages
Nail
Hair
Hair loss/
Baldness
Hypertrichosis
Acneiform
eruption
Acne
Rosacea
Ungrouped
Follicularcysts
Inflammation
Ungrouped
Sweat
glands
Eccrine
Apocrine
Sebaceous
Retrieved from "https://en.wikipedia.org/w/index.php?title=Psoriatic_onychodystrophy&oldid=1314744027"
Category:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp